---
title: "Phreesia Announces Workforce Restructuring to Cut Operating Costs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285999384.md"
description: "Phreesia, Inc. announced a workforce restructuring plan to cut operating costs, eliminating about 220 positions, primarily contractors. The company expects minimal related costs, mainly in fiscal 2027, and anticipates significant annualized savings already factored into its Adjusted EBITDA outlook for fiscal 2027. Analyst ratings for PHR stock are mixed, with a Buy rating and a $9.00 price target, while Spark's AI Analyst rates it as Neutral due to improving fundamentals but concerns over valuation and revenue guidance."
datetime: "2026-05-11T21:18:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285999384.md)
  - [en](https://longbridge.com/en/news/285999384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285999384.md)
---

# Phreesia Announces Workforce Restructuring to Cut Operating Costs

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An announcement from Phreesia ( (PHR) ) is now available.

On May 7, 2026, Phreesia, Inc. implemented a restructuring plan aimed at reducing operating expenses and aligning its cost structure with current business priorities, including the elimination of about 220 positions, roughly half of which are contractor roles. The company said it does not expect the related costs to be material and anticipates they will be incurred primarily during fiscal 2027.

Phreesia expects the restructuring to generate meaningful annualized run-rate expense savings that were already incorporated into its Adjusted EBITDA outlook for fiscal 2027 issued on March 30, 2026. The company cautioned that these expectations depend on various assumptions, and actual costs and savings could differ materially, with the possibility of additional unforeseen expenses arising from the plan.

The most recent analyst rating on (PHR) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Phreesia stock, see the PHR Stock Forecast page.

**Spark’s Take on PHR Stock**

According to Spark, TipRanks’ AI Analyst, PHR is a Neutral.

The score is driven primarily by improving fundamentals—sharp margin expansion and a strong swing to positive operating/free cash flow—supported by earnings-call evidence of profitability progress. These positives are tempered by weaker technical trends (below key moving averages with negative MACD), very expensive valuation (P/E ~348 with no dividend yield), and reduced FY27 revenue guidance that raises uncertainty in a higher-margin segment.

To see Spark’s full report on PHR stock, click here.

**More about Phreesia**

Phreesia, Inc. is a healthcare technology company that provides digital patient intake and engagement solutions to medical practices, health systems and life sciences organizations. The company focuses on streamlining patient registration, improving practice workflows and enabling data-driven engagement across the healthcare ecosystem.

**Average Trading Volume:** 2,015,803

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $618M

For a thorough assessment of PHR stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [PHR.US](https://longbridge.com/en/quote/PHR.US.md)

## Related News & Research

- [18:35 ETPHR Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Phreesia, Inc.](https://longbridge.com/en/news/286477331.md)
- [15:30 ETPHR INVESTOR NOTICE: Faruqi & Faruqi, LLP Notifies Phreesia (PHR) Investors of Securities Class Action Deadline on July 13, 2026](https://longbridge.com/en/news/286457477.md)
- [AI face is taking over — and driving plastic surgeons crazy](https://longbridge.com/en/news/286641783.md)
- [Phreesia Sets Release Date for Fiscal First Quarter 2027 Results | PHR Stock News](https://longbridge.com/en/news/284886820.md)
- [<![CDATA[The Questions You Couldn’t Ask in Time: How Agentic AI Accelerates Market Entry]]>](https://longbridge.com/en/news/286300823.md)